News

COVID-19 causes hyperactivity in blood-clotting cells

Changes in blood platelets triggered by COVID-19 could contribute to the onset of heart attacks, strokes, and other serious complications in some patients who have the disease, according to University of Utah Health scientists. The researchers found that inflammatory proteins produced during infection significantly alter the function of platelets, making them "hyperactive" and more prone to form dangerous and potentially deadly blood clots.

advertisement

They say better understanding the underlying causes of these changes could possibly lead to treatments that prevent them from happening in COVID-19 patients. Their report appears in Blood, an American Society of Hematology journal.

"Our finding adds an important piece to the jigsaw puzzle that we call COVID-19," says Robert A. Campbell, Ph.D., senior author of the study and an assistant professor in the Department of Internal Medicine. "We found that inflammation and systemic changes, due to the infection, are influencing how platelets function, leading them to aggregate faster, which could explain why we are seeing increased numbers of blood clots in COVID patients."

Emerging evidence suggests COVID-19 is associated with an increased risk of blood clotting, which can lead to cardiovascular problems and organ failure in some patients, particularly among those with underlying medical problems such as diabetes, obesity, or high blood pressure.

To find out what might be going on, the researchers studied 41 COVID-19 patients hospitalized at University of Utah Hospital in Salt Lake City. Seventeen of these patients were in the ICU, including nine who were on ventilators. They compared blood from these patients with samples taken from healthy individuals who were matched for age and sex.

Using differential gene analysis, the researchers found that SARS-CoV-2, the virus that causes COVID-19, appears to trigger genetic changes in platelets. In laboratory studies, they studied platelet aggregation, an important component of blood clot formation, and observed COVID-19 platelets aggregated more readily. They also noted that these changes significantly altered how platelets interacted with the immune system, likely contributing to inflammation of the respiratory tract that may, in turn, result in more severe lung injury.

Surprisingly, Campbell and his colleagues didn t detect evidence of the virus in the vast majority of platelets, suggesting that it could be promoting the genetic changes within these cells indirectly.

One possible mechanism is inflammation, according to Bhanu Kanth Manne, Ph.D., one of the study s lead authors and a research associate with the University of Utah Molecular Medicine Program (U2M2). In theory, inflammation caused by COVID-19 could affect megakaryocytes, the cells that produce platelets. As a result, critical genetic alterations are passed down from megakaryocytes to the platelets, which, in turn, make them hyperactive.

In test tube studies, the researchers found that pre-treating platelets from SARS-CoV-2 infected patients with aspirin did prevent this hyperactivity. These findings suggest aspirin may improve outcomes; however, this will need further study in clinical trials. For now, Campbell warns against using aspirin to treat COVID-19 unless recommended by your physician.

In the meantime, the researchers are beginning to look for other possible treatments.

"There are genetic processes that we can target that would prevent platelets from being changed," Campbell says. "If we can figure out how COVID-19 is interacting with megakaryocytes or platelets, then we might be able to block that interaction and reduce someone s risk of developing a blood clot."

This study titled, "Platelet Gene Expression and Function in COVID-19 Patients," was funded by the National Institutes of Health, the University of Utah Health 3i Initiative, and the American Heart Foundation.

Materials provided by University of Utah Health . Note: Content may be edited for style and length.

University of Utah Health. "COVID-19 causes hyperactivity in blood-clotting cells." ScienceDaily. ScienceDaily, 30 June 2020. .

University of Utah Health. "COVID-19 causes hyperactivity in blood-clotting cells." ScienceDaily. www.sciencedaily.com/releases/2020/06/200630125129.htm (accessed June 30, 2020).

advertisement

1

June 25, 2020 — Scientists have discovered a hitherto unknown function of blood platelets in cancer. In mouse models, these platelets have proved to help preserve the vascular barrier which makes blood-vessel walls ...

Feb. 13, 2019 — What do heart disease, stroke, sepsis, and cancer have in common, aside from being deadly diseases? They re all linked to platelets, the cells in our blood that normally help our blood clot. New ...

Nov. 8, 2017 — The first view of the physical mechanism of how a blood clot contracts at the level of individual platelets is giving researchers a new look at a natural process that is part of blood clotting. The ...

July 17, 2017 — A new technique that makes blood clots optically clear is allowing researchers to use powerful optical microscopy techniques to study the 3D structure of dangerous clots for the first time. Although ...
Read more on sciencedaily.com
News Topics :
Similar Articles :
Technology
A new tool using cutting edge technology is able to distinguish different types of blood clots based on what caused them, according to a study published in eLife. advertisement The tool...
Science
Studies abound that point to a role for plain old aspirin in keeping deadly cancers at bay. While aspirin is not yet part of mainstream treatment for any cancer, it...
Science
Using video microscopy in the living mouse lung, UC San Francisco scientists have revealed that the lungs play a previously unrecognized role in blood production. As reported online March 22,...
Science
Platelet decoys surrounded here by collagen fibers could help us better understand platelet biology and potentially be a treatment for some patients. Anna Waterhouse, Anne Laure Papa, Donald Ingber/Wyss Institute at Harvard...
Science
Researchers in the Department of Biomedical Engineering at Texas A&M University are working on an entirely new way to detect blood clots, especially in pediatric patients. advertisement Unlike what a...